DAMMENT, STEPHEN,FRANKLIN, RICHARD,ERUSALIMSKY, JORGE DANIEL
申请号：
PL15817516
公开号：
PL3236967T3
申请日:
2015.12.22
申请国别(地区):
PL
年份:
2020
代理人:
摘要：
The present invention relates to the use of the anti-megakaryocytic agent anagrelide or a therapeutically active metabolite thereof, in the prevention and/or treatment of metastatic disease in cancer patients displaying paraneoplastic thrombocytosis.
